PharmaVoice

MARCH 21, 2025

Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.

243

243

Drug Channels

MARCH 21, 2025

Todays guest post comes from Greg Skalicky, President of EVERSANA. Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). He introduces us to EVERSANA DIRECT Commercialization, a direct-to-patient change/model. To learn more about EVERSANA DIRECT Commercialization and how the direct-to-patient model can help you, meet with EVERSANA at the Asembia Summit in Las Vegas

98

98

Pharmaceutical Technology

MARCH 21, 2025

J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.

104

104

World Pharma News

MARCH 21, 2025

AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme platform technology. Under the terms of the agreement, AstraZeneca will acquire worldwide rights to use ALT-B4 to develop and commercialise subcutaneous formulations of several oncology assets. Alteogen will be responsible for clinical and commercial supply of ALT-B4 to AstraZeneca.

99

99

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharmaceutical Technology

MARCH 21, 2025

J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.

100

100

Pharmaceutical Technology

MARCH 21, 2025

Menarini Group has announced a partnership with VisualDx to enhance the diagnosis of individuals with BPDCN.

100

100

BioPharma Dive

MARCH 21, 2025

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

87

87

pharmaphorum

MARCH 21, 2025

Novartis' oral complement inhibitor Fabhalta has become the first approved treatment for rare kidney disease C3G as it chases a $3bn sales target

83

83

Pharmacy Times

MARCH 21, 2025

The study aims to address lingering public concerns, but its findings and communication have the potential to impact vaccine confidence and public health efforts.

Vaccines 72

Vaccines Communication 72

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

BioPharma Dive

MARCH 21, 2025

Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio. But executives argue its “compelling and highly differentiated value” justify the higher charge.

70

70

Pharmaceutical Technology

MARCH 21, 2025

Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the disease.

69

69

Pharmaceutical Commerce

MARCH 21, 2025

The presentation suggests ways to educate patients on the options available to them, with the hope of ultimately improving health outcomes.

66

66

pharmaphorum

MARCH 21, 2025

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

59

59

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmaceutical Technology

MARCH 21, 2025

Understanding reuse rights and copyright compliance is critical, particularly in todays ever-evolving technological landscape.

59

59

pharmaphorum

MARCH 21, 2025

PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.

59

59

Pharmaceutical Technology

MARCH 21, 2025

Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts.

59

59

pharmaphorum

MARCH 21, 2025

J&J's Tremfya gets a much-anticipated FDA approval for Crohn's disease, which the company thinks will be key to a renewed phase of sales growth.

59

59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

MARCH 21, 2025

Proposed cuts to National Institutes of Health funding threaten innovation necessary to fuel advances in patient care, researchers and provider groups say.

57

57

pharmaphorum

MARCH 21, 2025

Pharma is running out of names. Can an AI help? Jonah.

59

59

BioPharma Dive

MARCH 21, 2025

The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.

57

57

pharmaphorum

MARCH 21, 2025

4th ALS Drug Development Summit Sara.

Drug Development 59

Drug Development 59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmacy Times

MARCH 21, 2025

Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.

55

55

The Happy PharmD

MARCH 21, 2025

Pharmacists are supposed to have stable, well-paying careers. Thats what were told, right? Get the degree, pass the exams, land the job, and enjoy a predictable life. But what happens when the safe path starts to feel like a cage? Ariel Tsai knows exactly what that feels like. She did everything rightpursued pharmacy, earned her degree, got licensed.

52

52

Pharmacy Times

MARCH 21, 2025

This subset of heart failure requires unique therapeutic considerations.

52

52

epicur

MARCH 21, 2025

Get up-to-date treatment protocols and practical guidance that will help you confidently manage FIP cases in your practice.

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

MARCH 21, 2025

Patients with central nervous system (CNS) involvement achieved favorable outcomes with chimeric antigen receptor (CAR) T-cell therapy.

52

52

Pharmaceutical Commerce

MARCH 21, 2025

Jonathan James, CEO, Hope Charities, discusses the challenge of nonprofits securing sustainable funding while ensuring patients are aware of available assistance.

52

52

BioPharma Dive

MARCH 21, 2025

The PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.

52

52